Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

NCT00195091 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped PI left MSKCC

Conditions

Breast Cancer

Interventions

DRUG: Tetrathiomolybdate

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]